PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Alberta Precision Laboratories, Public Health Laboratory, Calgary, Alberta, Canada. Electronic address: kanti.pabbaraju@albertaprecisionlabs.ca.\', \'Alberta Precision Laboratories, Public Health Laboratory, Calgary, Alberta, Canada.\', \'Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Alberta, Canada; Alberta Precision Laboratories, Public Health Laboratory, Edmonton, Alberta, Canada; Department Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.\', \'Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Alberta, Canada; Alberta Precision Laboratories, Public Health Laboratory, Edmonton, Alberta, Canada; Department Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-0934(21)00090-210.1016/j.jviromet.2021.114151
?:hasPublicationType
?:journal
  • Journal of virological methods
is ?:pmid of
?:pmid
?:pmid
  • 33839186
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.858
?:rankingScore_hIndex
  • 88
?:title
  • Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all